InvestorsHub Logo
Followers 113
Posts 8346
Boards Moderated 0
Alias Born 02/27/2016

Re: None

Wednesday, 05/13/2020 10:44:18 PM

Wednesday, May 13, 2020 10:44:18 PM

Post# of 686738
Vraiment ?





Umibe5690 Wednesday, 05/13/20 09:59:55 PM
Re: iwasadiver post# 282440 0
Post # of 282517
You are right on target. LG has unequivocally declared that the UK is ready to go forward with approvals and that NWBO is one of three companies that will receive expedited review. The reviewer period is 3 to 4 months.

Sawston will be ready to handle about 50 patients per month to start and LG expects about $ 60'million in revenues in a 12 month period.

Insofar as the warrant extensions are concerned, with restricted exercise until November1,2020 is concerned, LP is not the only one with that deal. There are about 95 million warrants so extended. I voiced my concerns about this essentially " free" deal stating that this deal does not convey fair value to NWBO. Accredited investors who paid cash, such as myself, provided at least fairer value more commensurate with the value of extension of expiring warrants. As of now, the value of LP and other similarly placed investors is CONTINGENT.
For example, as I explained to LG, TLD may not issue during this 6 month period and further dilutions may take place rendering the restriction virtually worthless. While LG did not agree, of course I am not surprised, he did say that TLD will absolutely be announced within the restrictive period, implicitly conveying the notion that TLD release during this period is NOT a contingent event. They expect a short squeeze upon release during the restrictive period--another contingent event--spiking the SP. In any event, the take from all this is that Insofar as LG is concerned TLD will definitely be released during this period. He did say that the ASM schedule was still on track for data lock and TLD.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News